Tempest Therapeutics, Inc. (TPST)
0.89
-0.02
(-2.08%)
USD |
NASDAQ |
Sep 10, 10:12
Tempest Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 19.19 |
| June 26, 2026 | 18.84 |
| June 25, 2026 | 18.32 |
| June 24, 2026 | 20.24 |
| June 23, 2026 | 21.90 |
| June 22, 2026 | 21.81 |
| June 18, 2026 | 21.46 |
| June 17, 2026 | 21.81 |
| June 16, 2026 | 21.81 |
| June 15, 2026 | 21.81 |
| June 12, 2026 | 21.98 |
| June 11, 2026 | 21.81 |
| June 10, 2026 | 22.16 |
| June 09, 2026 | 22.16 |
| June 08, 2026 | 22.16 |
| June 05, 2026 | 22.16 |
| June 04, 2026 | 22.68 |
| June 03, 2026 | 22.16 |
| June 02, 2026 | 22.86 |
| June 01, 2026 | 25.30 |
| May 29, 2026 | 26.70 |
| May 28, 2026 | 30.18 |
| May 27, 2026 | 31.23 |
| May 26, 2026 | 30.88 |
| May 22, 2026 | 32.45 |
| Date | Value |
|---|---|
| May 21, 2026 | 31.58 |
| May 20, 2026 | 32.45 |
| May 19, 2026 | 31.06 |
| May 18, 2026 | 31.76 |
| May 15, 2026 | 31.93 |
| May 14, 2026 | 36.47 |
| May 13, 2026 | 32.10 |
| May 12, 2026 | 33.50 |
| May 11, 2026 | 33.85 |
| May 08, 2026 | 34.72 |
| May 07, 2026 | 34.37 |
| May 06, 2026 | 35.24 |
| May 05, 2026 | 37.51 |
| May 04, 2026 | 36.82 |
| May 01, 2026 | 35.59 |
| April 30, 2026 | 34.72 |
| April 29, 2026 | 30.36 |
| April 28, 2026 | 29.49 |
| April 27, 2026 | 30.01 |
| April 24, 2026 | 31.23 |
| April 23, 2026 | 31.41 |
| April 22, 2026 | 32.28 |
| April 21, 2026 | 30.88 |
| April 20, 2026 | 33.85 |
| April 17, 2026 | 34.20 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.644 |
| Alnylam Pharmaceuticals, Inc. | 24.92 |
| Anika Therapeutics, Inc. | 2.055 |
| Savara, Inc. | 7.599 |
| Vericel Corp. | 5.274 |
Price to Book Value Related Metrics
| Price | 0.89 |
| Earnings Yield | -503.9% |
| Market Cap | 14.22M |